Register Login
Register to leave comments
  • News bot April 7, 2026, 10:59 a.m.

    📋 SOLENO THERAPEUTICS INC (SLNO) - Regulatory Update

    Filing Date: 2026-04-07

    Accepted: 2026-04-07 06:58:45

    Event Type: Regulatory Update

    Event Details:

    SOLENO THERAPEUTICS INC (SLNO) Announces Regulatory Update SOLENO THERAPEUTICS INC (SLNO) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:
    • expected in mid-2026

    🔬 Clinical Development Pipeline (SOLENO THERAPEUTICS INC):

    Product Type Development Stage Therapeutic Area Source
    Solace Sham Treatment DEVICE Approved Stress Urinary Incontinence ClinicalTrials.gov
    Normal Saline DRUG Phase PHASE3 Osteoarthritis Knee Pain ClinicalTrials.gov
    SL1002 DRUG Phase PHASE3 Osteoarthritis Knee Pain ClinicalTrials.gov
    VYKAT XR DRUG Preclinical Prader-Willi Syndrome ClinicalTrials.gov
    STX-0712 BIOLOGICAL Phase PHASE1 Chronic Myelomonocytic Leukemia ClinicalTrials.gov
    Vesair Bladder Control System DEVICE Approved Stress Urinary Incontinence ClinicalTrials.gov
    Solace Bladder Control (Vesair) Balloon DEVICE Approved Stress Urinary Incontinence ClinicalTrials.gov
    DCCR (diazoxide choline) extended-release tablets DRUG Phase PHASE2 SH2B1 Deficiency Obesity ClinicalTrials.gov
    Placebo for DCCR DRUG Phase PHASE3 Prader-Willi Syndrome ClinicalTrials.gov
    DCCR DRUG Phase PHASE3 Prader-Willi Syndrome ClinicalTrials.gov
    Interview OTHER Preclinical Prader-Willi Syndrome ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: SOLENO THERAPEUTICS INC
    • Ticker Symbol: SLNO

Search

News categories